Table 2 Sensitivity, specificity, ACC, PPV and NPV in each tumor subtype
Sensitivity (%) | Specificity (%) | ACC (%) | PPV (%) | NPV (%) | |
|---|---|---|---|---|---|
All patients (n = 265) | 79.2 | 89.6 | 88.7 | 43.2 | 97.7 |
Luminal subtype (n = 161) | 100 | 93.0 | 93.2 | 21.4 | 100 |
Luminal/HER2 subtype (n = 24) | 0 | 77.3 | 70.8 | 0 | 89.5 |
HER2-enriched subtype (n = 32) | 80.0 | 72.7 | 75.0 | 57.1 | 88.9 |
Triple-negative subtype (n = 44) | 88.9 | 91.4 | 90.9 | 72.7 | 97.0 |